Guest guest Posted July 25, 2007 Report Share Posted July 25, 2007 July 22, 2007 Celsentri (Maraviroc) Interaction Warning Based on a recent drug interaction study, Pfizer is warning that the dose of Celsentri (maraviroc) needs to be altered if the drug is combined with Tibotec’s etravirine and/or Prezista. July 20, 2007 No Lipodystrophy Approval for Serostim The Food and Drug Administration (FDA) declined this week to approve EMD Serono’s Serostim for the treatment of HIV-associated adipose redistribution syndrome (HARS)—the accumulation of fat associated with lipodystrophy. As a result, patient access to the drug for HARS will likely be difficult to secure. Regards, VergelProgram for Wellness RestorationPoWeRUSA dot org“I had rather attempt something great and fail, than to attempt nothing at all and succeed.†R. SchullerGet a sneak peek of the all-new AOL.com. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.